Phosphatidylinositol/NN
3-kinase/NN
couples/VBZ
the/DT
interleukin-2/NN
receptor/NN
to/TO
the/DT
cell/NN
cycle/NN
regulator/NN
E2F/NN
./.

Cell/NN
cycle/NN
progression/NN
initiated/VBN
by/IN
interleukin-2/NN
(/(
IL-2/NN
)/)
in/IN
T/NN
cells/NNS
is/VBZ
critical/JJ
for/IN
lymphoproliferation/NN
and/CC
an/DT
immune/JJ
response/NN
./.
=====
Phosphatidyl/NN
inositol/NN
3-kinase/NN
(/(
PI3K/NN
)/)
is/VBZ
activated/VBN
by/IN
IL-2/NN
./.
=====
However/RB
,/,
nuclear/JJ
targets/NNS
for/IN
PI3K/NN
are/VBP
not/RB
known/VBN
./.
=====
Here/RB
we/PRP
identify/VBP
the/DT
cell/NN
cycle/NN
regulator/NN
E2F/NN
as/IN
an/DT
IL-2/NN
target/NN
in/IN
T/NN
lymphocytes/NNS
and/CC
PI3K/NN
as/IN
the/DT
critical/JJ
signaling/NN
pathway/NN
./.
=====
We/PRP
eliminate/VBP
both/CC
Stat5/NN
and/CC
Raf/MEK/NN
pathways/NNS
from/IN
E2F/NN
regulation/NN
./.
=====
Protein/NN
kinase/NN
B/NN
(/(
PKB/NN
)/)
is/VBZ
activated/VBN
by/IN
IL-2/NN
via/IN
PI3K/NN
./.
=====
The/DT
expression/NN
of/IN
an/DT
active/JJ
PKB/NN
is/VBZ
sufficient/JJ
to/TO
induce/VB
E2F/NN
activity/NN
./.
=====
Inhibition/NN
of/IN
PI3K/NN
inhibits/VBZ
phosphorylation/NN
of/IN
Rb/NN
,/,
induction/NN
of/IN
cyclin/NN
D3/NN
,/,
and/CC
degradation/NN
of/IN
p27kip1/NN
./.
=====
These/DT
results/NNS
establish/VBP
a/DT
crucial/JJ
PI3K/PKB-mediated/JJ
link/NN
between/IN
the/DT
IL-2/NN
teceptor/NN
and/CC
the/DT
cell/NN
cycle/NN
machinery/NN
./.